Resources
The Current ARG SYNOPSIS Newsletter
Atlantic Research Group publishes a quarterly newsletter to keep stakeholders informed about site updates, conference plans, news, press releases, blog […]
July 27, 2022
ARG Conference and Travel News
ARG, with offices in Charlottesville, London, Amsterdam, Steinhausen, Warsaw, and Sydney, is supporting its locations and therapeutic expertise with 2022 […]
May 23, 2022
The ARG Oncology Academy: “Committed to Furthering Research”
The ARG Oncology Academy is a training and development program that provides staff with the skills and tools necessary to […]
March 2, 2022
Do You Have Visibility into Your CRO’s processes?
We are cost-conscious, financially responsible, and considerate of budgets, yet understand and clearly communicate how additional activities could add value and reduce time to market.
July 6, 2021
Does Your CRO Value Every Single Patient?
Every patient counts. While large-scale intricately-designed studies can afford to lose patients, clinical trials for rare patient populations are not buffered for atrophy. ARG emphasizes that every patient is vital; in fact, we place the utmost importance on every data point in every study.
May 20, 2021
Is Your CRO Experienced in Clinical Trials With No Clear Pathways?
ARG has “been there and done that” when it comes to operationalizing rare disease clinical trials. Our maturity can be seen in creating deep relationships, which allow us to get things done with no preexisting roadmap.
April 5, 2021